![](/img/cover-not-exists.png)
First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors
Piha-Paul, Sarina A., Sachdev, Jasgit C., Barve, Minal, LoRusso, Patricia, Szmulewitz, Russell, Patel, Sapna Pradyuman, Lara, Primo N., Chen, Xiaotian, Hu, Beibei, Freise, Kevin J., Modi, Dimple, SoodVolume:
25
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-19-0578
Date:
November, 2019
File:
PDF, 743 KB
2019